Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: Observations from the TIMI 8 trial
- 1 February 2002
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 143 (2) , 229-234
- https://doi.org/10.1067/mhj.2002.120405
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina)Published by Elsevier ,2000
- Clinical Outcomes of Bivalirudin for Ischemic Heart DiseaseCirculation, 1999
- Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trialThe Lancet, 1999
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Hirudin in Acute Myocardial InfarctionCirculation, 1996
- Hirulog in the Treatment of Unstable AnginaCirculation, 1995
- Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.Circulation, 1994
- Anticoagulant effects of hirulog, ∗∗Hirulog™ brand direct thrombin inhibitor. a novel thrombin inhibitor, in patients with coronary artery diseaseThe American Journal of Cardiology, 1993
- TRIAL OF HEPARIN VERSUS ATENOLOL IN PREVENTION OF MYOCARDIAL INFARCTION IN INTERMEDIATE CORONARY SYNDROMEThe Lancet, 1981